Renin-angiotensin system antagonists are associated with lower mortality in hypertensive patients with COVID-19.
Renin-angiotensin system antagonists are associated with lower mortality in hypertensive patients with COVID-19. Scott Med J. 2020 Nov; 65(4):123-126.